AOP Health

AOP Health Receives Market Authorization for Landiolol in Canada

December 13, 2023 08:55 AM Eastern Standard Time VIENNA–(BUSINESS WIRE)–At the end of November 2023, AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health Authority (Health Canada) for its ultra-short-acting, cardioselective β1-blocker Landiolol. The drug is used in intensive care to treat atrial fibrillation and atrial flutter (supraventricular tachycardia) and non-compensatory sinus tachycardia, hence when … Continue reading AOP Health Receives Market Authorization for Landiolol in Canada

MedSurvey

Sonia DeMarco Joins MedSurvey as VP of Strategic Accounts

Medical Market Research Company Announces New Senior-Level Hire December 12, 2023 10:05 AM Eastern Standard Time SOUTHAMPTON, Pa.–(BUSINESS WIRE)–MedSurvey, a leading medical market research company, is pleased to announce that it has appointed Sonia DeMarco as Vice President of Strategic Accounts. In her new role, she will be focused on leading partnerships with key accounts and ensuring overall project success. This new senior-level hire reflects … Continue reading Sonia DeMarco Joins MedSurvey as VP of Strategic Accounts

Clarify Health Solutions

Clarify Health Announces Leadership Transition

Jean Drouin to Step Down as CEO, Remain a Board Member and Senior Advisor Terry Boch, Chief Commercial Officer at Clarify, Named CEO December 07, 2023 06:00 PM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health Solutions, Inc. (“Clarify”), a leading healthcare analytics and value-based payment platform company, announced today that Jean Drouin, MD, founder and CEO of Clarify has decided to step down from his … Continue reading Clarify Health Announces Leadership Transition

Carta Healthcare

Carta Healthcare names Brent Dover CEO

Carta Healthcare closes series B, triples revenue, and brings in seasoned health tech leader Brent Dover to accelerate growth December 06, 2023 09:05 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Health tech company Carta Healthcare®, whose mission is to harness the value of clinical data, is pleased to announce the appointment of Brent Dover as chief executive officer. Dover succeeds former CEO Matt Hollingsworth who co-founded … Continue reading Carta Healthcare names Brent Dover CEO

Abcuro

Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors

December 06, 2023 07:00 AM Eastern Standard Time NEWTON, Mass.–(BUSINESS WIRE)–Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T and NK cells, today announced the appointment of Mark Pruzanski, M.D., as Chairman of its Board of Directors. Dr. Pruzanski brings more than 30 years of experience as a life sciences executive, entrepreneur … Continue reading Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors